Revenue
2013
2014
2015
2016
2017
2021
2022
2023
ORAGENICS INC (OGEN)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2013
2014
2015
2016
2018
2019
2021
2022
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $37,653 | $131,521 | $86,987 | — | — | — | $0 | $0 | $0 | $939,926 | $1.0M | $1.3M | $1.4M | $1.3M |
| Gross profit | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $570,329 | $688,879 | $453,303 | — | — |
| Research & development | $2.4M | $4.1M | $15.5M | $10.1M | $10.6M | $22.1M | $12.1M | $6.0M | $3.5M | $4.8M | $8.7M | $3.1M | $9.4M | $7.9M | $2.4M | $2.0M |
| Operating expenses | $9.4M | $10.6M | $20.9M | $14.6M | $15.9M | $26.6M | $15.9M | $10.0M | $6.7M | $8.5M | $11.8M | $6.4M | $16.9M | $12.9M | $8.1M | $8.3M |
| Operating income | −$9.4M | −$10.6M | −$20.9M | −$14.4M | −$15.8M | −$26.6M | −$15.9M | −$10.0M | −$6.7M | −$8.5M | −$11.8M | −$5.8M | −$16.2M | −$12.4M | −$7.3M | −$7.9M |
| EBITDAderived | — | — | −$20.9M | −$14.4M | −$15.7M | −$26.6M | −$15.8M | −$10.0M | −$6.7M | −$8.5M | −$11.7M | −$5.8M | −$16.1M | −$12.4M | −$7.3M | −$7.9M |
| Net income | −$9.8M | −$10.6M | −$20.7M | −$14.3M | −$15.7M | −$26.4M | −$15.6M | −$9.9M | −$6.7M | −$7.0M | −$11.7M | −$5.8M | −$16.1M | −$13.1M | −$7.7M | −$7.8M |
| Basic EPSper diluted share | -$4.56 | -$47.88 | -$9.18 | -$7.11 | -$8.09 | -$0.47 | -$0.37 | -$0.87 | -$1.37 | -$1.57 | -$0.32 | -$0.16 | -$0.56 | -$0.74 | -$1.34 | -$1.42 |
| Diluted EPSper diluted share | -$4.56 | -$47.88 | -$9.18 | -$7.11 | -$0.14 | -$0.47 | -$0.37 | -$0.87 | -$1.37 | -$1.57 | -$0.32 | -$0.16 | -$0.56 | -$0.74 | -$1.34 | -$1.42 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 12, 2025Form 4/A | Telling FredDirector | SellCommon Stock | 210 | $0.94 | $197.40 | 948 |
| Dec 12, 2025Form 4 | Telling FredDirector | SellCommon Stock | 210 | $0.94 | $197.40 | 34.5K |
| Jun 18, 2025Form 4 | Odyssey Health, Inc.TenPercentOwner | SellCommon Stock - OGEN | 5.0K | $4.26 | $21.5K | 0 |
| Jun 17, 2025Form 4 | Odyssey Health, Inc.TenPercentOwner | SellCommon Stock - OGEN | 2.0K | $4.46 | $8.9K | 5.0K |
| Jun 16, 2025Form 4 | Odyssey Health, Inc.TenPercentOwner | SellCommon Stock - OGEN | 5.0K | $4.45 | $22.3K | 7.0K |